AZ Brushes Off Vaccine Criticism, Awaits US Readout

WHO Endorsement Counters Fears

 
• By Andrew McConaghie

While fast-developing news on COVID-19 is grabbing the headlines, oncology will continue to drive growth in 2021.

AZ Vaccines
AstraZeneca's COVID-19 vaccine: fears on efficacy could be allayed by US Phase III results, expected within the next few weeks.

More from Clinical Trials

More from R&D